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Severe Left Ventricular Dyssynchrony
Is Associated With Poor Prognosis in
Patients With Moderate Systolic Heart
Failure Undergoing Coronary Artery Bypass Grafting
Martin Penicka, MD, PHD,* Jozef Bartunek, MD, PHD,§ Otto Lang, MD, PHD,†
Karel Medilek, MD,‡ Petr Tousek, MD,* Marc Vanderheyden, MD,§ Bernard De Bruyne, MD, PHD,§
Michaela Maruskova, MD,* Petr Widimsky, MD, PHD*
Prague and Hradec Kralove, Czech Republic; and Aalst, Belgium
Objectives The objective of the present study was to assess the relationship between the presence of left ventricular (LV)
dyssynchrony and clinical outcome in patients with moderate systolic heart failure undergoing coronary artery
bypass graft (CABG) surgery.
Background The presence of LV dyssynchrony is associated with poor prognosis in patients with LV dysfunction.
Methods The study consisted of 215 consecutive patients with ischemic cardiomyopathy and dyspnea (age 65  9 years,
81% male) undergoing CABG. Dyssynchrony was calculated by tissue Doppler imaging from regional time inter-
vals in basal LV segments before and 1 month after CABG. Myocardial viability was assessed using single-
photon emission computed tomography (SPECT) before CABG.
Results Twenty-five patients (11.6%) died within 30 days (in-hospital mortality) of CABG. The presence of pre-CABG dys-
synchrony 119 ms had the highest predictive accuracy for in-hospital mortality, with a sensitivity of 84% and a
specificity of 71%. During the median follow-up period of 359 days (interquartile range 219 to 561), an addi-
tional 19 patients (10.3%) died and 34 patients (18.5%) were hospitalized for worsening heart failure. At Cox
regression analysis, post-CABG dyssynchrony 72 ms and 5 viable segments were identified as independent
predictors of clinical events, with a hazard ratio (HR) of 5.02, 95% confidence interval (CI) 2.57 to 10.02 (p 
0.001), and an HR of 0.63, 95% CI 0.55 to 0.75 (p  0.001), respectively. Patients without post-CABG dyssyn-
chrony and with viable myocardium had excellent prognosis compared with patients with severe post-CABG dys-
synchrony and nonviable myocardium (event rate 3% vs. 64%; p  0.001).
Conclusions The presence of severe LV dyssynchrony is associated with poor clinical outcomes despite revascularization.
These results advocate a routine assessment of both LV dyssynchrony and viability to predict outcome in systolic
heart failure patients undergoing CABG surgery. (J Am Coll Cardiol 2007;50:1315–23) © 2007 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.03.070t
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doronary artery bypass graft (CABG) surgery improves
rognosis in patients with ischemic cardiomyopathy and
ngina (1–2). In contrast, in patients with left ventricular
LV) dysfunction who have dyspnea as the main symptom,
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ccepted March 19, 2007.he role of surgical revascularization is poorly defined (3).
hese patients are scarce in clinical trials, and it is contro-
ersial whether they benefit from revascularization. Obser-
ational studies (4) have emphasized the need for detection
f myocardial viability to identify patients with reversible
ysfunction, in whom survival may improve after CABG
urgery. However, a significant number of patients with a
arge area of viable myocardium do not experience func-
ional and prognostic improvement despite CABG surgery
5). In contrast, several studies have reported a survival
enefit of postsurgical revascularization, irrespective of the
egree of viability (6), or recovery of left ventricular ejection
raction (LVEF) (7). This suggests that, in patients with
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Heart Failure, Dyssynchrony, and Prognosis After CABG October 2, 2007:1315–23heart failure, the assessment of
myocardial viability alone is not
accurate enough to predict out-
come after revascularization and
that other variables may be im-
portant. Cardiac dyssynchrony is
associated with functional deteri-
oration and poor prognosis in
advanced systolic heart failure
(8–11). Correction of dyssyn-
chrony with biventricular pacing
improves symptoms, LVEF, and
survival (12). The objective of
the present study was to assess
the prevalence of pre- and post-
CABG LV dyssynchrony and its
relationship to clinical outcome
n patients with stable ischemic cardiomyopathy and dys-
nea as the predominant symptom.
ethods
atients. This was a prospective multicenter study. Be-
ween June 2002 and December 2005, 215 consecutive
atients (age 65  9 years, 81% male) with ischemic
ardiomyopathy, undergoing CABG surgery, who fulfilled
he inclusion/exclusion criteria were recruited to the study.
nclusion criteria included: 1) effort dyspnea (New York
eart Association [NYHA] functional class I, II, or III) as
he main cardiovascular symptom for at least 3 months; and
) stable LV dysfunction with LVEF 40% for at least 3
onths. Patients with NYHA functional class IV symptoms
uring the 30-day period before CABG surgery, acute
oronary syndrome in the previous 3 months, any valvular
eart disease requiring surgery, malignancy, sustained ven-
ricular tachycardia, or survivors of cardiac arrest were
xcluded from the study. All patients recruited to the study
ad CABG surgery as the sole procedure. No patients
nderwent concomitant LV remodeling, aneurysmectomy,
itral valve repair, or Maze procedure. The study was
pproved by the ethical committee of each institution. All
atients gave written informed consent before recruitment.
tudy protocol. In the week leading up to CABG surgery,
ach patient underwent echocardiography and tissue Dopp-
er imaging (TDI) to assess LV volumes, LVEF, and
re-CABG LV dyssynchrony. In addition, myocardial per-
usion and glucose uptake were assessed by single-photon
mission computed tomography (SPECT) using technetium-
9m tetrofosmin and F18-fluorodeoxyglucose, respectively.
he TDI was repeated 1 month after surgery to record
ost-CABG dyssynchrony. At 6-month follow-up, echo-
ardiography was repeated to assess LV volumes and LVEF.
chocardiography and TDI. All studies were performed
ith a commercially available system equipped with TDI
Vivid 7, Vingmed-General Electric, Horten, Norway). The
Abbreviations
and Acronyms
CABG  coronary artery
bypass graft
Em  peak early diastolic
mitral annular velocity
LV  left ventricular
LVEF  left ventricular
ejection fraction
Sm  peak early systolic
mitral annular velocity
SPECT  single-photon
emission computed
tomography
TDI  tissue Doppler
imagingV volumes and LVEF were assessed in apical 4- and r-chamber views using the biplane Simpson method. The
DI was performed in pulsed wave mode. In 3 apical views
4-, 3-, and 2-chamber), longitudinal myocardial velocities
ere recorded in 6 basal segments of the LV. Moreover,
eak mitral annular velocities during systole (Sm) and early
iastole (Em) were assessed as the mean from 4 corners of
he mitral annulus (septal, lateral, anterior, and inferior).
ample volume was placed in the middle of each basal
egment. Gain and filters were adjusted to obtain an optimal
issue signal. Myocardial velocities were recorded at end-
xpiration at a sweep speed of 100 mm/s. All studies were
tored both in digital (raw data) format and on S-VHS
ideotape for off-line analysis. The mean from 3 consecutive
eats was taken for each measurement. Echocardiographers
ere blinded to clinical follow-up data.
ssessment of LV dyssynchrony by TDI. To assess the
re- and post-CABG LV dyssynchrony, time delay between
he onset of QRS complex on the surface electrocardiogram
nd the onset of the systolic velocity wave on the TDI
ecording was assessed in each basal LV segment. Dyssyn-
hrony was calculated as the difference between the shortest
nd the longest time delay in the 6 basal segments. Thus,
V dyssynchrony represents a delay in the onset of contrac-
ion between the segment with the earliest and the segments
ith the latest systolic wall motion (13). Intra- and inter-
bserver variability for the assessment of LV dyssynchrony
ere 7.1% and 8.2%, respectively.
ssessment of viability by SPECT. In brief (5),
echnetium-99m tetrofosmin (600 MBq) was injected in-
ravenously to evaluate resting perfusion. After a light meal
nd administration of acipimox, F18-fluorodeoxyglucose
185 MBq) was injected intravenously to assess myo-
ardial glucose uptake. Dual-isotope simultaneous
mage acquisition was performed 45 min after F18-
uorodeoxyglucose injection using high-energy 511-keV
ollimators. A symmetrical 15% energy window was
reset on each side of the 140-keV photon peak of
echnetium-99m tetrofosmin and 511-keV photon peak
f F18-fluorodeoxyglucose. Data were acquired over 360°
nd stored in a 64  64 computer matrix. The images were
isplayed as polar maps, which were normalized to maxi-
um activity (set at 100%). To assess myocardial viability,
olar maps were divided into 16 segments. Segments
howing normal perfusion of technetium-99m tetrofosmin
nd segments with perfusion defect but preserved or in-
reased F18-fluorodeoxyglucose (perfusion-metabolism
ismatch) were considered to be viable. Segments with a
atch (concordantly reduced perfusion and metabolism)
ere considered to be nonviable.
tatistical analysis. Data are presented as mean  SD or
edian and interquartile range (IQR). Two-sided paired
nd unpaired Student t test or Pearson correlation coeffi-
ient were used as appropriate. The Fisher exact test was
sed to compare categoric variables in 2  2 contingency
able. In cases where the contingency table had more than 2
ows or 2 columns, the chi-square test was used. Receiver-
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October 2, 2007:1315–23 Heart Failure, Dyssynchrony, and Prognosis After CABGperating characteristic (ROC) curves were constructed to
ssess optimal cutoff values for LV dyssynchrony and the
umber of dysfunctional viable segments required to predict
linical events. Independent predictors of death from any
ause and hospitalization for worsening heart failure were
dentified using the Cox proportional hazard model and
xpressed as a hazard ratio (HR) and 95% confidence
nterval (CI). Cumulative survival curves for composite of
eath from any cause and hospitalization for worsening
eart failure were derived according to the Kaplan-Meier
ethod, and differences between curves were analyzed by
og-rank statistics. For all tests, p  0.05 was considered to
e significant. All analyses were conducted using SPSS
oftware (version 13, SPSS Inc., Chicago, Illinois).
esults
hirty-day outcome. A total of 25 patients (11.6%) died
ithin 30 days after CABG surgery. The causes of deaths
ere refractory heart failure in 23 patients and sepsis in 2
atients. Table 1 shows baseline characteristics in the
0-day survivors and nonsurvivors. Patients had on average
.5  0.8 significantly stenosed coronary arteries. Complete
evascularization of all stenosed lesions was obtained in 189
Baseline Characteristics According to 30-Day O
Table 1 Baseline Characteristics According
No
Age, yrs
Male gender, n (%)
Diabetes mellitus, n (%)
Prior myocardial infarction, n (%)
Stenosed coronary arteries, n
ACE inhibitors, n (%)
Beta-blockers, n (%)
Loop diuretics, n (%)
Amiodarone, n (%)
Angina pectoris, n (%)
NYHA functional class
Duration of heart failure, yrs
Logistic EuroSCORE (%)
Atrial fibrillation, n (%)
QRS duration, ms
Left bundle branch block, n (%)
LV end-diastolic volume, ml
LV end-systolic volume, ml
LVEF, %
Pre-CABG mitral regurgitation, n (%)
None or mild
Moderate (grades 2/4 and 2/4)
Sm, cm/s
Em, cm/s
Pre-CABG LV dyssynchrony, ms
Severe (119 ms) pre-CABG dyssynchrony, n (%)
Dysfunctional viable segments, n (%)
ACE  angiotensin-converting enzyme; CABG  coronary artery by
interquartile range; LV  left ventricular; LVEF  left ventricular eject
mitral annular velocity.88%) of patients. fPatients who died within 30 days after surgery had
ignificantly greater pre-CABG LV dyssynchrony and a
maller area of viable myocardium than survivors (p 
.001) (Fig. 1). Other baseline clinical and echocardio-
raphic variables, including the EuroSCORE, were similar
n both groups. At ROC analysis, the presence of pre-
ABG surgery dyssynchrony of 119 ms (sensitivity 84%,
pecificity 71%) and 5 dysfunctional viable segments
sensitivity 72%, specificity 61%), showed the highest pre-
ictive accuracy for in-hospital mortality (Fig. 2). The
revalence of severe (119 ms) pre-CABG dyssynchrony in
he entire cohort was 36%. Twenty-one (27%) of 77 patients
ith severe pre-CABG dyssynchrony died compared with
nly 4 (3%) of 138 patients without significant dyssyn-
hrony (p  0.001, Fisher exact test).
utcome from day 31 to the end of the follow-up
eriod. Six patients (3.2%) who had an acute coronary
yndrome during this follow-up period were excluded.
hus, a total of 184 patients (age 66  9 years, 84% male)
ho survived the first 30 days after CABG surgery entered
he analysis. During median follow-up of 359 days (IQR
19 to 561 days), an additional 19 patients (10.3%) died and
4 patients (18.5%) were hospitalized for worsening heart
e
-Day Outcome
vors (n  25) Survivors (n  190) p Value
 8 65 9 NS
(76) 156 (82) NS
(36) 76 (40) NS
(60) 137 (72) NS
 0.8 2.5 0.8 NS
(72) 129 (68) NS
(80) 162 (85) NS
(80) 136 (72) NS
(8) 10 (5) NS
(52) 94 (50) NS
 1.0 2.3 1.1 NS
R 0.7–1.5) 1.0 (IQR 0.6–1.5) NS
 13.3 8.0 16.1 NS
(16) 29 (15) NS
 31 106 23 NS
(12) 20 (11) NS
 29 153 41 NS
 35 107 36 NS
 6 30 6 NS
(84) 158 (83) NS
(16) 32 (17)
 1.2 2.4 1.3 NS
 1.4 2.5 1.5 NS
 63 79 55 0.001
(84) 56 (29) 0.001
 1.8 5.9 3.6 0.001
rafting; Em  peak early diastolic mitral annular velocity; IQR 
tion; NYHA  New York Heart Association; Sm  peak early systolicutcom
to 30
nsurvi
66
19
9
15
2.4
18
20
20
2
13
2.5
1.2 (IQ
9.1
4
110
3
155
112
28
21
4
2.3
2.4
186
21
3.7
pass gailure. All of the observed deaths were cardiovascular (9
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Heart Failure, Dyssynchrony, and Prognosis After CABG October 2, 2007:1315–23udden cardiac and 10 pump failure deaths). No patient was
ost to follow-up, and survival status was established in all
ndividuals. Table 2 shows baseline and 1-month post-
ABG surgery clinical and echocardiographic characteris-
ics in patients with and without clinical events. Patients
ith a clinical event were older than patients without an
vent. In addition, patients with clinical events had smaller
ost-CABG Sm and Em (p  0.05), greater pre- and
ost-CABG dyssynchrony (p  0.001), and less viable
Figure 1 Pre-CABG Dyssynchrony and Myocardial Viability in 30
Degree of the pre-CABG left ventricular dyssynchrony (left) and degree of viable m
in patients who died versus survived during the first 30 days after CABG. CABG 
Figure 2 Pre-CABG Dyssynchrony,
Myocardial Viability, and 30-Day Mortality
Agreement between the presence (DYS) or absence (DYS) of severe pre-
CABG left ventricular dyssynchrony (119 ms) (top), the absence (viable) or
presence ( viable) of viable myocardium (5 viable segments) (bottom) and
the 30-day mortality. AUC  area under curve; CABG  coronary artery bypass
graft; DYS  dyssynchrony.myocardium (p  0.001) than patients without clinical
vents. Other clinical variables and degree of LV remodel-
ng were similar between groups.
ndependent predictors of death from any cause and
ospitalization for worsening heart failure between day
1 to the end of the follow-up period. The ROC curves
ere constructed to analyze the accuracy of the 3 baseline
ariables with the greatest difference between the groups to
redict clinical events (Fig. 3). Post-CABG dyssynchrony,
ith a cut-off value of 72 ms (n  77 patients), showed
he highest accuracy to predict clinical events. The accuracy
f the number of dysfunctional but viable segments (cut-off
alue 5 segments [n  88 patients]) and pre-CABG
yssynchrony (cut-off value72 ms [n 94 patients]) were
ower than post-CABG dyssynchrony. In Cox regression
nalysis (Table 3), post-CABG LV dyssynchrony 72 ms
nd5 dysfunctional but viable segments were identified as
he independent predictors of all-cause death and heart
ailure hospitalization. Table 4 and Figure 4 show clinical
utcome in 4 groups of patients divided according to the
egree of post-CABG dyssynchrony (72 vs. 72 ms) and
xtent of viable myocardium (5 viable segments vs. 5
iable segments). Patients with significant post-CABG
yssynchrony and a small extent of viable myocardium had
he highest event rate (64%) and significantly shorter
vent-free survival (p  0.001) compared with the 3 other
roups. In contrast, patients without post-CABG dyssyn-
hrony and with a large extent of viable myocardium had
xcellent outcome, with an event rate of 3%, and signifi-
antly longer event-free survival (p  0.001) than the
ther groups. Intermediate event rates were observed in
atients without post-CABG dyssynchrony but with small
xtent of viable myocardium and in patients with significant
ost-CABG dyssynchrony but large extent of viable
Survivors and Nonsurvivors
ium (right)
ary artery bypass grafting.-Day
yocard
coronyocardium.
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October 2, 2007:1315–23 Heart Failure, Dyssynchrony, and Prognosis After CABGmpact of surgery on LV dyssynchrony. The prevalence of
ignificant (72 ms) pre- and post-CABG dyssynchrony
as 51% and 42%, respectively. The pre-CABG dyssyn-
hrony correlated significantly with the post-CABG dys-
ynchrony (r  0.73; r2  0.53; p  0.001). Twenty-seven
29%) of 94 patients with significant pre-CABG surgery
yssynchrony (72 ms) showed minor dyssynchrony (72
s) after CABG, and none of these patients experienced
ny clinical events during the follow-up period. Ten (11%)
Figure 3 Accuracy of LV Dyssynchrony and Myocardial
Viability to Predict Long-Term Clinical Events
Receiver-operating characteristic curves to predict clinical events occurring from
day 31 after CABG to the end of the follow-up period for pre- and post-CABG
left ventricular dyssynchrony and the number of dysfunctional but viable seg-
ments. Sp  specificity; Ss  sensitivity; other abbreviations as in Figure 2.
Baseline and 1-Month Post-CABG CharacteristicWithout Clinical Events Between Day 31 After C
Table 2 Baseline and 1-Month Post-CABG CWithout Clinical Events Between Da
 Clinical Ev
Age, yrs 69
Male gender, n (%) 43 (8
Diabetes mellitus, n (%) 23 (4
Prior myocardial infarction, n (%) 42 (7
Angina pectoris, n (%) 28 (5
NYHA functional class 2.4
Duration of heart failure, yrs (IQR) 1.1 (0
Atrial fibrillation, n (%) 8 (1
QRS duration, ms 114
Left bundle branch block, n (%) 10 (1
LV end-diastolic volume, ml 154
LV end-systolic volume, ml 110
LVEF, % 30
Post-CABG mitral regurgitation, n (%)
None or mild 45 (8
Moderate (grades 2/4 and 2/4) 7 (1
More than moderate (grade 2/4) 1 (2
Post-CABG Sm, cm/s 2.4
Post-CABG Em, cm/s 2.6
Pre-CABG LV dyssynchrony, ms 106
Post-CABG LV dyssynchrony, ms 105
Dysfunctional viable segments, n (%) 4.1
Post-CABG indicates 1 month after CABG. *p  0.001 pre-CABG versu
Abbreviations as in Table 1.rf 90 patients without pre-CABG dyssynchrony developed
ignificant dyssynchrony after CABG. Of note, all of these
atients had nonviable myocardium.
elationship of post-CABG LV dyssynchrony with func-
ional and clinical outcome. Table 5 shows baseline and
-month follow-up characteristics of patients with (n  77)
nd without (n  107) significant (72 ms) post-CABG
yssynchrony. The baseline clinical variables and degree of
V remodeling were similar in both groups. Patients with
ignificant post-CABG dyssynchrony had a smaller extent
f viable myocardium and greater pre-CABG dyssynchrony
han patients without post-CABG dyssynchrony. At the
-month follow-up, patients without post-CABG dyssyn-
hrony had superior functional and clinical outcome com-
ared with patients with significant post-CABG dyssyn-
hrony. Both groups showed a significant reduction in
ngina and NYHA functional class. However, greater im-
rovement (p  0.01) was observed in patients without
ost-CABG dyssynchrony. The LVEF also increased in
oth groups, but significantly more (p  0.001) in patients
ithout post-CABG dyssynchrony. The LV volumes de-
reased only in patients without post-CABG dyssynchrony.
ost-CABG dyssynchrony showed a significant correlation
ith the change in both LV end-systolic volume (r  0.30;
 0.001) and LVEF (r  0.51; p  0.001) between
aseline and 6-month follow-up. Furthermore, a higher
ercentage of patients without post-CABG dyssynchrony
elt improved by surgery compared with patients with
Patients With andnd End of Follow-Up Period
teristics in Patients With and
After CABG and End of Follow-Up Period
 53)  Clinical Event (n  131) p Value
62 9 0.01
112 (85) NS
47 (36) NS
95 (73) NS
64 (49) NS
2.3 1.1 NS
) 1.0 (0.7–1.5) NS
21 (16) NS
105 23 NS
10 (8) 0.04
152 35 NS
108 34 NS
30 6 NS
105 (80) NS
21 (16)
5 (4)
2.7 1.4 0.03
3.0 1.5 0.01
70 58 0.001
46 37* 0.001
6.6 3.4 0.001
CABG dyssynchrony in patients without a clinical event.s inABG
harac
y 31
ent (n
9
1)
3)
9)
3)
1.0
.7–1.4
5)
29
9)
35
32
6
5)
3)
)
1.2
1.4
62
70
3.3esidual post-CABG dyssynchrony (p  0.01, Fisher exact
t
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Heart Failure, Dyssynchrony, and Prognosis After CABG October 2, 2007:1315–23est). Finally, 42 clinical events (55%; 16 deaths) occurred in
7 patients with significant post-CABG dyssynchrony com-
ared with only 11 events (10%) in 107 patients without
ost-CABG dyssynchrony (p  0.001, Fisher exact test).
edian event-free survival was significantly longer in pa-
ients without post-CABG dyssynchrony (p  0.01).
iscussion
he present study investigated the prevalence of significant
re- and post-CABG LV dyssynchrony and its relationship
o clinical outcome in 215 patients with stable ischemic
eart failure undergoing CABG surgery. Main findings can
e summarized as follows: 1) severe pre-CABG dyssyn-
hrony was present in approximately one-third of the
atients, and its presence was associated with increased
n-hospital mortality; 2) CABG surgery alone was insuffi-
ient to resynchronize the LV contraction pattern in the
ajority of patients, although patients who experienced a
ajor reduction in dyssynchrony after CABG surgery had
uperb long-term prognosis; and 3) post-CABG dyssyn-
hrony and myocardial viability emerged as independent
HR by Cox Regression Analysis for a Compositeospitalizations for Worsening Heart Failure FroF llow-Up Period
Table 3
HR by Cox Regression Analysis for
Hospitalizations for Worsening Hear
Follow-Up Period
Univaria
HR
Age 1.16
Male gender 0.82
Diabetes mellitus 1.18
NYHA functional class 1.10
Pre-CABG QRS duration 1.00
Pre-CABG LV end-diastolic volume 0.99
Pre-CABG LV end-systolic volume 1.00
Pre-CABG LVEF 1.03
Post-CABG Sm 0.86
Post CABG Em 0.78
Post-CABG LV dyssynchrony 72 ms 6.58
5 dysfunctional viable segments 0.50
Post-CABG indicates 1 month after CABG.
CI  confidence interval; HR  hazard ratio; other abbreviations as
Clinical Outcome From Day 31 After CABG to Eof Patients According to Degree of Post-CABG D
Table 4 Clinical Outcome From Day 31 Afteof Patients According to Degree of
Death From
Any Cause
(n  19)
Post-CABG dyssynchrony 72 ms
and 5 viable segments (n  63)
0
Post-CABG dyssynchrony 72 ms
and 5 viable segments (n  44)
3 (7%)
Post-CABG dyssynchrony 72 ms
and 5 viable segments (n  25)
2 (8%)
Post-CABG dyssynchrony 72 ms
and 5 viable segments (n  52)
14 (27%)
p value (chi-square test) 0.001CABG  coronary artery bypass graft.redictors of long-term survival and hospitalization for
eart failure, with dyssynchrony being the best predictor.
atients without LV dyssynchrony, both before and after
ABG surgery, and with a large segment of viable myocar-
ium had excellent 30-day and long-term prognosis. In
ontrast, patients with severe dyssynchrony had a poor
utcome irrespective of degree of viability. These results
dvocate routine assessment for LV dyssynchrony, in addi-
ion to myocardial viability, in patients with systolic heart
ailure undergoing CABG.
evascularization in systolic heart failure. Ischemic heart
ailure is a leading cause of hospitalization in developed
ountries. Because the outcome of medical therapy remains
nsatisfactory (4,14), other therapeutic modalities such as
evascularization or resynchronization have to be consid-
red. Myocardial revascularization improves survival in pa-
ients with chronic coronary artery disease and potentially
eversible LV dysfunction (3). Recent meta-analyses have
emonstrated a strong relationship between the presence of
yocardial viability and improved survival after CABG
urgery (4,14). Absence of viability was associated with a
eath From Any Cause ory 31 After CABG to the End of
posite of Death From Any Cause or
lure From Day 31 After CABG to the End of
alysis Multivariable Analysis
p Value HR (95% CI) p Value
0.05
NS
NS
NS
NS
NS
NS
NS
NS
0.05
0.001 5.02 (2.57–10.02) 0.001
0.001 0.63 (0.55–0.75) 0.001
e 1.
Follow-Up Period in 4 Groupsnchrony and Myocardial Viability
G to End of Follow-Up Period in 4 Groups
-CABG Dyssynchrony and Myocardial Viability
Heart Failure
Hospitalization
(n  34)
Composite of Death From Any
Cause and Heart Failure
Hospitalization (n  53)
2 (3%) 2 (3%)
6 (14%) 9 (21%)
7 (28%) 9 (36%)
19 (37%) 33 (64%)
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ent strategy; yet the majority of patients included in those
tudies had angina as the main cardiovascular symptom, and
he number of patients with predominantly heart failure
ymptoms were small (1–4). Furthermore, data on the role
f viability testing from observational studies are conflicting
6,7). Samady et al. (7) showed a similar outcome in both
roups of patients with and without improvement of LVEF
fter CABG surgery. In patients with ischemic systolic heart
ailure (6), early revascularization was associated with mark-
dly lower 3-year mortality compared with medical therapy
20% vs. 34%, respectively) in patients both with and
ithout viable myocardium. Thus, it remains unclear how
o select patients with heart failure who might benefit from
ABG surgery. Despite the lack of consistent evidence,
xpert consensus recommends revascularization in patients
ith failing myocardium and the presence of myocardial
iability (15). In the present study, we found that, in
ddition to the presence of myocardial viability, the absence
Figure 4 Long-Term Mortality and Hospitalizations According
to Degree of Post-CABG DYS and Myocardial Viability
Kaplan-Meier estimates of the time to death from any cause or hospitalization
for worsening heart failure between day 31 after CABG to the end of the
follow-up period in patients without post-CABG dyssynchrony (72 ms) and
with large area (5 segments) of viable myocardium (blue solid line), patients
without post-CABG dyssynchrony (72 ms) and with small area (5 segments)
of viable myocardium (green dotted line), patients with significant post-CABG
dyssynchrony (72 ms) and large area (5 segments) of viable myocardium
(red solid line), and patients with significant post-CABG dyssynchrony (72
ms) and small area (5 segments) of viable myocardium (orange dashed
line). Pairwise comparison between groups is shown in accompanying table.
CABG  coronary artery bypass grafting; DYS  dyssynchrony.f LV dyssynchrony is a strong predictor of favorable sn-hospital and long-term outcome. In the present study,
0-day mortality in the entire cohort was 11.6%. The
ajority of deaths were observed in patients with severe
re-CABG LV dyssynchrony and nonviable myocardium.
n contrast, all patients without pre-CABG surgery LV
yssynchrony and with viable myocardium survived surgery
ithout complications. During the long-term follow-up, an
dditional 28.8% of patients died or had hospitalization for
eart failure. The presence of post-CABG LV dyssyn-
hrony and nonviable myocardium indicated poor progno-
is, with a 64% event rate, whereas the absence of dyssyn-
hrony was associated with good outcomes (10% event rate)
rrespective of the degree of viability. Furthermore, in
atients without dyssynchrony, survival benefit was associ-
ted with a greater improvement in symptoms and LVEF
ompared with patients with dyssynchrony. Reversed LV
emodeling was observed only in patients without
yssynchrony.
V dyssynchrony in systolic heart failure. In patients
ith systolic heart failure, the prevalence of LV dyssyn-
hrony ranges from 20.8% to 79.6% (16) and is associated
ith a significantly higher risk of cardiac events (10,11) in
edically treated patients. The present study extends these
ndings by showing a strong relationship between the
resence of severe pre- or post-CABG LV dyssynchrony
nd early and late adverse clinical outcome in patients with
eart failure undergoing CABG surgery. Myocardial isch-
mia is one of the major causes of LV dyssynchrony (17),
nd one may speculate that correction of ischemia by CABG
urgery should resynchronize LV contractions. Gibson
t al. (18) reported complete resolution of LV dyssynchrony
fter CABG surgery in 12 (86%) of 14 patients with
reserved ejection fraction. In the present study of heart
ailure patients, those with the most severe dyssynchrony
ad a poor perioperative course. In addition, among survi-
ors only 29% showed a reduction in dyssynchrony by
ABG surgery. That suggests that extensive LV dyssyn-
hrony cannot be reversed by CABG surgery and that
ersistent high-degree dyssynchrony hinders LV pump
unction recovery in the early postoperative period. Thus, in
atients with dilated and dysfunctional LV, reduction of
schemia alone may not be sufficient to eliminate LV
yssynchrony. Accordingly, the present findings raise the
ypothesis that use of cardiac resynchronization therapy in
atients with heart failure undergoing CABG surgery may
mprove the short- and long-term prognosis in addition to
yocardial revascularization.
tudy limitations. The study patients had mostly mod-
rate heart failure with a median duration of 1 year. The
esults are not applicable to patients with more severe
eart failure, especially to patients in NYHA functional
lass IV or patients with advanced LV remodeling,
ong-term LV dysfunction, or valvular heart disease. In
he present study, LV dyssynchrony was assessed from
he maximal difference between any 2 of 6 basal LV
egments. This method has been shown to be inferior in
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iventricular pacing to techniques that use standard
eviation of the values in either a 6- or, optimally,
2-segment model (19). In the present study, no patient
nderwent prophylactic defibrillator implantation for the
ollowing reasons. First, all heart failure patients included
n our study underwent full surgical revascularization. As
result, our study population was not comparable to that
ncluded in MADIT (Multicenter Automatic Defibrilla-
or Implantation Trial)-II. Furthermore, there are
urrently no clear recommendations for prophylactic
efibrillator implantation shortly after complete or near-
o-complete myocardial revascularization. Second, cur-
ent reimbursement guidelines in the authors’ countries
o not allow preventive defibrillator implantation in this
tudy population. Nevertheless, because 47% of patients
ied suddenly during follow-up, prophylactic defibrillator
mplantation after CABG should be considered in some
atients with ischemic heart failure.
onclusions
he presence of severe pre- and post-CABG LV dyssyn-
hrony was associated with high in-hospital and long-term
ortality in patients with ischemic heart failure undergoing
yocardial revascularization. Therefore, noninvasive testing
o assess LV dyssynchrony should be performed before
ABG surgery to guide patient selection. After CABG
urgery, assessment of LV dyssynchrony should be repeated
o optimize patient management. High-risk patients with
evere dyssynchrony might be considered for biventricu-
ar pacing before or after CABG surgery. These results
all for a prospective study to investigate the effects of
aseline and Follow-Up Characteristics in Patients With and Witho
Table 5 Baseline and Follow-Up Characteristics in Patients Wit
Post-CABG Dyssynchrony >
Baseline
(n  77)
Follow-Up
(n  72)*
Angina pectoris, n (%)* 43 (56) 19 (26)
NYHA functional class* 2.5 1.0 2.0 1.6
LV end-diastolic volume, ml* 155 35 149 40
LV end-systolic volume, ml* 112 36 106 51
LVEF, %* 31 6 34 11
Dysfunctional viable segments, n (%) 4.9 3.6
LV dyssynchrony, ms# 143 60 126 34
Improved by CABG, n (%)* 43 (56)
Death from any cause, n (%) 16 (21)
Heart failure hospitalization, n (%) 26 (34)
Composite of death from any cause and
heart failure hospitalization, n (%)
42 (55)
Median event-free survival, days 326 (IQR 205–479)
The 6-month functional follow-up data are reported in 72 patients with significant post-CABG dys
months after CABG. †p 0.05. ‡p 0.01. §p 0.001: follow-up patients with versus without sig
yssynchrony. #Follow-up (post-CABG) LV dyssynchrony was assessed within 1 month after CABG
Abbreviations as in Table 1.ardiac resynchronization therapy in patients with heartailure and severe LV dyssynchrony undergoing CABG
urgery.
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